Sei Soham Pharmatech Llp - Company Profile

It is a healthcare limited liability partnership based in Mumbai, Maharashtra, India, established in 2019.
2019 Mumbai, Maharashtra, India Active
Last Updated:
About Sei Soham Pharmatech Llp

Sei Soham Pharmatech Llp, a active limited liability partnership, was established on 11 April 2019 in Mumbai, Maharashtra, India. Engaging in medical & laboratory equipment within the healthcare sector, it holds LLPIN: AAO-8587. Registered under ROC Roc Mumbai. It has total obligation of contribution of ₹1.00 M.

Its leadership includes Vinay Padmakar Bhosekar (Designated Partner), Charu Chandra Upreti (Designated Partner). Past directors included Vinay Padmakar Bhosekar, Rajiv Ranjan Sharma, Ramashankar Kumar Sinha. Its latest date of accounts and solvency statement 31 March 2025. It is based at 203, Floor-2, Plot-294-145 1401 Zafryn Chambers, Sewree Koliwada Road, S, Ewree, Mumbai, Maharashtra, 400015.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAO-8587

  • Incorporation Date

    11 April 2019

  • Total Obligation of Contribution

    ₹1.00 M

  • ROC Code

    Roc Mumbai

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 1.00 M
  • Company Age 6 Year, 10 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 40.53%
  • Profit Growth **** -65.51%
  • Ebitda **** -79.84%
  • Total Assets **** 65.23%
Company report

Sei Soham Pharmatech Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sei Soham Pharmatech Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Sei Soham Pharmatech Llp?
Current Designated Partners
Name Designation Appointment Date Status
Vinay Padmakar Bhosekar Designated Partner 07 Dec 2023 Current
Charu Chandra Upreti Designated Partner 11 Apr 2019 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Partner 06 Dec 2023 Past
Pramod Abcsdd Partner 07 Dec 2023 Past
Pramod Abcsdd Designated Partner 07 Dec 2023 Past
Pramod Abcsdd Partner - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sei Soham Pharmatech Llp.

Sei Soham Pharmatech Llp, for the financial year ended 2023, experienced significant growth in revenue, with a 40.53% increase. The company also saw a substantial fall in profitability, with a 65.51% decrease in profit. The company's net worth witnessed no change by increase of 0%.

Sei Soham Pharmatech Llp revenue growth over time
Sei Soham Pharmatech Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
40.53%
*******
*******
*******
*******
Revenue from Operations
*******
40.73%
*******
*******
*******
*******
Total Assets
*******
65.23%
*******
*******
*******
*******
Profit or Loss
*******
-65.51%
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
-79.84%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sei Soham Pharmatech Llp?

Unlock access to Sei Soham Pharmatech Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Sei Soham Pharmatech Llp?

Unlock and access historical data on people associated with Sei Soham Pharmatech Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sei Soham Pharmatech Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sei Soham Pharmatech Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sei Soham Pharmatech Llp
Recent Activity within the Organization
  • Annual General Meeting

    The activity Sei Soham Pharmatech Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was completed.

  • Statement of Assets & Liabilities

    The activity Sei Soham Pharmatech Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.

  • Director Appointment

    The activity Vinay Padmakar Bhosekar was appointed as a Designated Partner was appointed as a Designated Partner on 07 Dec 2023 & has been associated with this company since 2 years 2 months . was completed.

  • Director Appointment

    Progress on Charu Chandra Upreti was appointed as a Designated Partner was appointed as a Designated Partner on 11 Apr 2019 & has been associated with this company since 6 years 10 months . was documented.

  • LLP Incorporation

    Progress on Sei Soham Pharmatech Llp was registered on 11 Apr 2019 with Roc Mumbai & aged 6 years 10 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Sei Soham Pharmatech Llp?

The LLPIN of Sei Soham Pharmatech Llp is AAO-8587.

Where is Sei Soham Pharmatech Llp headquartered?

Sei Soham Pharmatech Llp is headquartered at 203, Floor-2, Plot-294-145 1401 Zafryn Chambers, Sewree Koliwada Road, S, Ewree, Mumbai, Maharashtra, 400015.

When was Sei Soham Pharmatech Llp incorporated?

Sei Soham Pharmatech Llp was incorporated on 11 April 2019.

Who are the current directors of Sei Soham Pharmatech Llp?

The current directors of Sei Soham Pharmatech Llp are

What is the primary industry of Sei Soham Pharmatech Llp?

The primary industry of Sei Soham Pharmatech Llp is Healthcare.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available